TARGETING A NONONCOGENE ADDICTION TO THE AUTOCRINE SEMA3C GROWTH PATHWAY FOR THE TREATMENT OF LETHAL METASTATIC PROSTATE CANCER
$1,259,331FY2021Department of the ArmyDOD
The University Of British Columbia
Investigators
View source on USAspending →TARGETING A NONONCOGENE ADDICTION TO THE AUTOCRINE SEMA3C GROWTH PATHWAY FOR THE TREATMENT OF LETHAL METASTATIC PROSTATE CANCER · GrantIndex